论文部分内容阅读
小儿支气管肺炎是儿科常见病、多发病。过去治疗小儿支气管肺炎,多采用各种抗菌素。磺胺类药物临床应用虽已40年,但由于抗药菌株逐渐增多,近几年临床应用较少。自无产阶级文化大革命以来,我国制成了多种新的磺胺类药物,经国内大量的临床资料观察,均认为磺胺类药物仍为有相当价值的抗感染药物,对防治一些感染性疾病有着重要作用。现将我科应用增效磺胺甲氧吡嗪(简称 TMP—SMPZ)治疗小儿支气管肺炎29例总结报导如下。
Pediatric bronchopneumonia is a common pediatric disease, frequently-occurring disease. In the past treatment of children with bronchial pneumonia, the use of a variety of antibiotics. Although the clinical application of sulfa drugs for 40 years, but gradually increased drug-resistant strains, less clinical applications in recent years. Since the Great Proletarian Cultural Revolution, China has made a number of new sulfonamides. According to a large amount of clinical data in China, sulfa drugs are still considered as valuable anti-infective drugs and important for the prevention and control of some infectious diseases effect. Now my department application synergistic sulfamethoxazole (TMP-SMPZ) treatment of children with bronchial pneumonia in 29 cases reported as follows.